1.上海中医药大学交叉科学研究院(上海 201203)
2.上海华盈生物医药科技有限公司(上海 201203)
赵东方,女,在读硕士生,主要从事天然酶抑制剂发现及药物代谢研究
王平,副研究员;E-mail:wangping12@dicp.ac.cn
[ "葛广波,男,博士,教授、博士生导师,上海中医药大学交叉科学研究院副院长。为国家优秀青年基金获得者、上海市曙光学者、上海市优秀学术带头人;兼任中华中医药学会中药实验药理学分会副秘书长、青委会副主任委员,中国药理学会药物代谢专业委员会青委会副主任委员,中国药理学会分析药理学专业委员会青委会副主任委员。主要从事药物代谢与代谢调控、酶抑制剂高效发现新技术与新方法研究,先后主持国家自然科学基金优秀青年基金、国家自然科学基金面上项目、国家重点研发计划“中医药现代化研究”重点专项等重大科研项目10余项;在Coordination Chemistry Reviews、J Am Chem Soc、Angew Chem Int Ed、Chem Sci、Biosens Bioelectron、ACS Sensors、Anal Chem、J Med Chem、Acta Pharmaceutica Sinica B、Chem Commun等国际权威学术刊物上发表SCI论文190余篇(含IF>5.0高水平论文50余篇),SCI总被引3 900余次,H因子35;申请各类发明专利90余项(含国际专利12项),已授权40余项。应邀担任Acta Pharmaceutica Sinica B、Journal of Ethnopharmacology、Chinese Chemical Letters、Journal of Pharmaceutical Analysis、Chinese Journal of Natural Medicines等SCI收录学术刊物及《药学学报》《中草药》《中国中药杂志》等中文核心刊物编委/青年编委;并担任Pharmacology & Therapeutics、Chem Sci、Med Res Rev、Theranostics、Biosens Bioelectron、J Med Chem、Anal Chem、Chem Commun等100余种学术刊物审稿人。曾荣获中国药学会-以岭生物医药青年奖、中华中医药学会中青年创新人才奖、上海市青年五四奖章、中国药理学会刘昌孝人才奖励基金“优秀青年科技工作者奖”等奖励。" ]
扫 描 看 全 文
赵东方, 何荣景, 侯旭东, 等. 源于天然的酶抑制剂高效发现及评价新技术:进展与展望[J]. 上海中医药大学学报, 2021,35(1):1-11,19.
ZHAO Dongfang, HE Rongjing, HOU Xudong, et al. New technologies for efficient discovery and evaluation of natural enzyme inhibitors: Research progress and perspectives[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(1):1-11,19.
赵东方, 何荣景, 侯旭东, 等. 源于天然的酶抑制剂高效发现及评价新技术:进展与展望[J]. 上海中医药大学学报, 2021,35(1):1-11,19. DOI: 10.16306/j.1008-861x.2021.01.001.
ZHAO Dongfang, HE Rongjing, HOU Xudong, et al. New technologies for efficient discovery and evaluation of natural enzyme inhibitors: Research progress and perspectives[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(1):1-11,19. DOI: 10.16306/j.1008-861x.2021.01.001.
从自然界广泛存在的药用资源中发现活性天然产物,进而作为先导化合物是创新药物研发的重要途径。然而,如何从成分复杂多样的动植物或微生物提取物中高效发现对目标酶具有强效抑制作用的天然产物,一直是酶抑制剂类药物研发领域面临的一大挑战。近年来,随着生命科学及计算机虚拟筛选等技术的蓬勃发展,加之现代分离分析技术的革新和相关前沿技术的突飞猛进,涌现出了多种高效发现和高通量筛选酶抑制剂的新技术与新方法。结合该领域的新近研究进展,着重介绍酶抑制剂发现领域的新方法与新技术,包括计算机虚拟筛选与人工智能识别技术、谱效结合、亲和超滤质谱技术、靶标键合色谱技术、基于光学底物的高通量筛选技术、基于酶活性的蛋白质组分析、基于赖氨酸标记的生物质谱以及蛋白芯片技术等,并对技术原理、优缺点和应用领域做了进一步阐述,且结合具体实例分享了上述前沿技术在酶抑制剂高效发现与抑制效应评价和抑制机制研究中的应用;同时,对如何实现更为高效、精确的酶抑制剂筛选和发现提出了展望,以期为源于天然的酶抑制剂高效发现及相关药理学研究提供系列关键技术及研究思路。
Discovery of the natural bioactive products from natural pharmaceutical resources as leading compounds is the major sources for the development of new drugs.However, in the fields of research and development of enzyme inhibitor agents, how to efficiently identify the natural products with strong inhibitory effect on target enzymes from the complex and diverse extracts of animals, plants or microorganisms, is still a big challenge.In recent years, with the vigorous development of life sciences and computer-aided virtual screening technology, as well as the innovation of modern separation and analytical techniques and related frontier technology, series of novel methods and technologies for efficient discovery and high-throughput screening of enzyme inhibitors have emerged.Based on the frontier research progress in this field, this paper reviews the new technologies and methodologies for efficient discovery and high-throughput screening of enzyme inhibitors, including computer-aided virtual screening and artificial intelligence based identification, fingerprint-efficacy correlation, affinity mass spectrometry, target enzyme binding biochromatography, optical substrate based high-throughput screening, activity-based protein profiling, lysine labeling based biomass spectrometry and protein microarray.This review covers the principles, the advantages and disadvantages and the application fields of the above-mentioned cutting-edge technologies, and also shares the cases in rapid discovery of enzyme inhibitors, assessment of inhibition potency and investigation of inhibitory mechanism by using the above-mentioned cutting-edge technologies.Meanwhile, how to achieve more efficient and accurate screening and discovery of enzyme inhibitors is prospected.It is expected that this review could provide series of new technologies and research ideas for rapid discovery of enzyme inhibitors from natural resources and for facilitating the related pharmacological research.
药物发现酶抑制剂高通量筛选计算机虚拟筛选蛋白芯片
drug discoveryenzyme inhibitorshigh-throughput screeningcomputer-assisted drug virtual screeningprotein microarray
MEYER U A. Overview of enzymes of drug metabolism[J]. J Pharmacokinet Biopharm,1996,24(5):449-459.
ALMAZROO O A,MIAH M K,VENKATARAMANAN R. Drug Metabolism in the Liver[J].Clin Liver Dis,2017,21(1):1-20.
IJZERMAN A P,GUO D. Drug-Target Association Kinetics in Drug Discovery[J].Trends Biochem Sci,2019,44(10):861-871.
GASHAW I,ELLINGHAUS P,SOMMER A,et al. What makes a good drug target?[J]. Drug Discov Today,2011,16(23-24):1037-1043.
BEUTLER J A. Natural Products as a Foundation for Drug Discovery[J].Curr Protoc Pharmacol,2019,86(1):e67.
TUN M K,HERZON S B. The pharmacology and therapeutic potential of(-)-huperzine A[J]. J Exp Pharmacol,2012,4:113-123. Doi:10.2147/JEP.S27084http://doi.org/10.2147/JEP.S27084.
HECK A M,YANOVSKI J A,CALIS K A. Orlistat,a new lipase inhibitor for the management of obesity[J].Pharmacotherapy,2000,20(3):270-279.
DINICOLANTONIO J J,BHUTANI J,O’KEEFE J H. Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes[J]. Open Heart,2015,2(1):e000327.
宋慧鹏,杨华,高雯,等.中药活性成分发现关键技术研究进展[J].世界科学技术-中医药现代化,2016:18(7):1093-1098.
BURNS K L,MAY S W. Separation methods applicable to the evaluation of enzyme-inhibitor and enzyme-substrate interactions[J].J Chromatogr B Analyt Technol Biomed Life Sci,2003,797(1-2):175-190.
IMADUWAGE K P,GO E P,ZHU Z,et al. HAMS:High-Affinity Mass Spectrometry Screening. A High-Throughput Screening Method for Identifying the Tightest-Binding Lead Compounds for Target Proteins with No False Positive Identifications[J].J Am Soc Mass Spectrom,2016,27(11):1870-1877.
HAGA J H,ICHIKAWA K,DATE S. Virtual Screening Techniques and Current Computational Infrastructures[J]. Curr Pharm Des,2016,22(23):3576-3584.
GLAAB E. Building a virtual ligand screening pipeline using free software:a survey[J].Brief Bioinform,2016,17(2):352-366.
KRUGER D M,EVERS A. Comparison of structure- and ligand- based virtual screening protocols considering hit list complementarity and enrichment factors[J]. Chem Med Chem,2010,5(1):148-158.
VON BEHREN M M,RAREY M. Ligand-based virtual screening under partial shape constraints[J].J Comput Aided Mol Des,2017,31(4):335-347.
YAN X,LIAO C,LIU Z,et al. Chemical Structure Similarity Search for Ligand-based Virtual Screening:Methods and Computational Resources[J].Curr Drug Targets,2016,17(14):1580-1585.
DE SOUSA LUIS J A,BARROS R P C,DE SOUSA N F,et al. Virtual screening of natural products database[J/OL]. Mini Rev Med Chem,2020,20(19):1-9. doi: 10.2174/1389557520666 200730161549http://doi.org/10.2174/1389557520666 200730161549.
BANEGAS-LUNA A J,CERÓN-CARRASCO J P,PÉREZ-SÁNCHEZ H. A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data[J].Future Med Chem,2018,10(22):2641-2658.
BIANCO G,GOODSELL D S,FORLI S. Selective and Effective:Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors[J].Trends Pharmacol Sci,2020,41(12):1038-1049.
UPADHYAY J,GAJJAR A,SUHAGIA B N. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors[J]. Curr Drug Discov Technol,2019,16(4):426-436.
VUORINEN A,ENGELI R,MEYER A,et al. Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors[J]. J Med Chem,2014,57(14):5995-6007.
FORLI S,HUEY R,PIQUE M E,et al. Computational protein-ligand docking and virtual drug screening with the AutoDock suite[J].Nat Protoc,2016,11(5):905-919.
LYNE D P. Structure-based virtual screening:an overview[J]. Drug Discov Today,2002,7(20):1047-1055.
RIPPHAUSEN P,NISIUS B,BAJORATH J. State-of-the-art in ligand-based virtual screening[J].Drug Discov Today,2011,16(9-10):372-376.
SPYRAKIS F,CAVASOTTO C N. Open challenges in structure-based virtual screening:Receptor modeling,target flexibility consideration and active site water molecules description[J].Arch Biochem Biophys,2015,583:105-119.
DIGHE S N,DEORAa G S,DELA MORA E,et al. Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening[J].J Med Chem,2016,59(16):7683-7689.
ZENG L J,LIN B,SONG H T. Progress in study of spectrum-effect relationship of traditional Chinese medicine and discussions[J]. Zhongguo Zhongyao Zazhi,2015,40(8):1425-1432.
WANG L J,JIANG Z M,XIAO P T,et al. Identification of anti-inflammatory components in Sinomenii Caulis based on spectrum-effect relationship and chemometricmethods[J]. J Pharm Biomed Anal,2019,167:38-48.
WANG Y L,HU G,ZHANG Q,et al. Screening and Characterizing Tyrosinase Inhibitors from Salviamiltiorrhiza and Carthamustinctorius by Spectrum-Effect Relationship Analysis and Molecular Docking[J]. J Anal Methods Chem,2018,2018:2141389.doi:10.1155/2018/2141389http://doi.org/10.1155/2018/2141389.
王利强,常春艳,娄婷婷,等.基于谱效关系的α-糖苷酶抑制剂筛选方法研究[J].食品研究与开发,2015,36(24):30-33.
WANG J M,PENG L N,SHI M J,et al. Spectrum Effect Relationship and Component Knock-Out in Angelica Dahurica Radix by High Performance Liquid Chromatography-Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer[J]. Molecules,2017,22(7):1231.
WANG L,GUAN X Q,HE R J,et al.Pentacyclictriterpenoid acids in Styrax as potent and highly specific inhibitors against human carboxylesterase 1A[J].Food Funct,2020,11(10):8680-8693.
LIU Y J,LI S Y,HOU J,et al. Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark[J].Fitoterapia,2016,115:57-63.
PETRE B A. Affinity-mass spectrometry approaches for elucidating structures and interactions of protein-ligand complexes[J].Adv Exp Med Biol,2014,806:129-151.
周慧,王义民,郑重,等.亲和超滤质谱技术在中药活性成分筛选中的研究进展[J].质谱学报,2018,39(6):641-652.
WHITEHURST C E,ANNIS D A. Affinity selection-mass spectrometry and its emerging application to the high throughput screening of G protein-coupled receptors[J]. Comb Chem High Throughput Screen,2008,11(6):427-438.
NIESSEN S,MCLEOD I,YATES J R. Overview of affinity purification in combination with mass spectrometry[J]. CSH Protoc,2006,2006(7):pdb.top3. doi:10.1101/pdb.top3http://doi.org/10.1101/pdb.top3.
QIN S S,MENG M M,YANG D H,et al. High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening[J].Chem Sci,2018,9(12):3192-3199.
JONKER N,KOOL J,IRTH H,et al. Recent developments in protein-ligand affinity mass spectrometry[J].Anal Bioanal Chem,2011,399(8):2669-2681.
ZHANG B J,ZHAO S M,YANG D H,et al. A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts[J].ACS Cent Sci,2020,6(2):213-225.
YANG J R,LUO J G,KONG L Y. Determination of α-glucosidase inhibitors from Scutellariabaicalensis using liquid chromatography with quadrupole time of flight tandem mass spectrometry coupled with centrifugal ultrafiltration[J].Chin J Nat Med,2015,13(3):208-214.
XIE L H,XIE J H,XU Y,et al. Discovery of anthocyanins from cranberry extract as pancreatic lipase inhibitors using a combined approach of ultrafiltration,molecular simulation and spectroscopy[J].Food Funct,2020,11(10):8527-8536.
CAO H M,YU R,CHOI Y S,et al. Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation[J]. Pharmacol Res,2010,61(6):519-524.
刘嘉君,贾晓妮,王静,等.受体色谱:中药靶向活性成分高效筛选技术[J].世界科学技术-中医药现代化,2018,20(8):1476-1481.
ZHAO X F,LI Q,BIAN L J,et al. Using immobilized G-protein coupled receptors to screen bioactive traditional Chinese medicine compounds with multiple targets[J].J Pharm Biomed Anal,2012,70:549-552.
CHEN X F,WU Y L,CHEN C,et al. Identifying potential anti-COVID-19 pharmacological components oftraditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening[J].Acta Pharm Sin B,2020. doi:10.1016/j.apsb.2020.10.002http://doi.org/10.1016/j.apsb.2020.10.002.
CHEN X L,XUE S,LIN Y L,et al. Immobilization of porcine pancreatic lipase onto a metal-organic framework,PPL@MOF:A new platform for efficient ligand discovery from natural herbs[J]. Anal Chim Acta,2020,1099:94-102.
WARRIER S,KHARKAR P S. Fluorescent probes for biomedical applications(2009-2014)[J]. Pharm Pat Anal,2014,3(5):543-560.
REN W M,ZHANG J J,PENG C,et al. Fluorescent Imaging of β-Amyloid Using BODIPY Based Near-Infrared Off-On Fluorescent Probe[J].Bioconjug Chem,2018,29(10):3459-3466.
CHAI Y,GAO Y T,XIONG H W,et al. A near-infrared fluorescent probe for monitoring leucineaminopeptidase in living cells[J]. Analyst,2019,144(2):463-467.
QU P,MA X H,CHEN W S,et al. A coumarin-based fluorescent probe for ratiometric detection of hydrazine and its application in living cells[J].Spectrochim Acta A Mol Biomol Spectrosc,2019,210:381-386.
CHEN H,SUN T,QIAO X G,et al. Red-emitting fluorescent probe for detecting hypochlorite acid in vitro and in vivo[J].Spectrochim Acta A Mol Biomol Spectrosc,2018,204:196-202.
WU J J,GUAN X Q,DAI Z R,et al. Molecular probes for human cytochrome P450 enzymes:Recent progress and future perspectives[EB/OL]. Coordin Chem Rev,2021,427:213600. https://doi.org/10.1016/j.ccr.2020.213600https://doi.org/10.1016/j.ccr.2020.213600.
JUN M E,ROY B,AHN K H. “Turn-on” fluorescent sensing with “reactive” probes[J].Chem Commun(Camb),2011,47(27):7583-7601.
RATHBUN C M,PRESCHER J A. Bioluminescent Probes for Imaging Biology beyond the Culture Dish[J].Biochemistry,2017,56(39):5178-5184.
YAO Z,ZHANG B S,PRESCHER J A. Advances in bioluminescence imaging:new probes from old recipes[J]. Curr Opin Chem Biol,2018,45:148-156.
WELSH D K,NOGUCHI T. Cellular bioluminescence imaging[J]. Cold Spring Harb Protoc,2012,2012(8):pdb.top070607. doi:10.1101/pdb.top070607http://doi.org/10.1101/pdb.top070607.
PRÉVEL C,PELLERANO M,VAN T N,et al. Fluorescent biosensors for high throughput screening of protein kinase inhibitors[J].Biotechnol J,2014,9(2):253-265.
GARLAND M,YIM J J,BOGYO M. A Bright Future for Precision Medicine:Advances in Fluorescent Chemical Probe Design and Their Clinical Application[J]. Cell Chem Biol,2016,23(1):122-136.
TIAN X G,LIU T,LI L,et al. Visual High-Throughput Screening for Developing a Fatty Acid Amide Hydrolase Natural Inhibitor Based on an Enzyme-Activated Fluorescent Probe[J].Anal Chem,2020,92(14):9493-9500.
SONG Y Q,GUAN X Q,WENG Z M,et al. Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening[J].Int J Biol Macromol,2019,137:261-269.
DAI Z R,FENG L,JIN Q,et al. A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme:CYP1A1 as a case study[J].Chem Sci,2017,8(4):2795-2803.
NING J,LIU T,DONG P P,et al. Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2[J].J Am Chem Soc,2019,141(2):1126-1134.
SHEN L,NIU J,WANG C,et al. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses[J].J Virol,2019,93(12):e00023. doi:10.1128/JVI.00023-19http://doi.org/10.1128/JVI.00023-19.
LIU Y,PATRICELLI M P,CRAVATT B F. Activity-based protein profiling:the serine hydrolases[J].Proc Natl Acad Sci USA,1999,96(26):14694-14699.
CRAVATT B F,WRIGHT A T,KOZARICH J W. Activity-based protein profiling:from enzyme chemistry to proteomic chemistry[J].Annu Rev Biochem,2008,77:383-414.
JESSANI N,NIESSEN S,WEI B Q,et al. A streamlined platform for high-content functional proteomics of primary human specimens[J].Nat Methods,2005,2(9):691-697.
SPEERS A E,ADAM G C,CRAVATT B F. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne[3+2] cycloaddition[J].J Am Chem Soc,2003,125(16):4686-4687.
HEAL W P,DANG T H,TATE E W. Activity-based probes:discovering new biology and new drug targets[J].Chem Soc Rev,2011,40(1):246-257.
BENNS H J,WINCOTT C J,TATE E W,et al. Activity- and reactivity-based proteomics:Recent technological advances and applications in drug discovery[J].Curr Opin Chem Biol,2020,60:20-29.
NODWELL M B,SIEBER S A. ABPP methodology:introduction and overview[J].Top Curr Chem,2012,324:1-41.
王初,陈南.基于活性的蛋白质组分析[J].化学学报,2015,73(7):657-668.
WILLEMS L I,OVERKLEEFT H S,Van Kasteren S I. Current developments in activity-based protein profiling[J]. Bioconjug Chem,2014,25(7):1181-1191.
LEUNG D,HARDOUIN C,BOGER D L,et al. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes[J].Nat Biotechnol,2003,21(6):687-691.
LONG J Z,LI W W,BOOKER L,et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects[J].Nat Chem Biol,2009,5(1):37-44.
TSUBOI K,BACHOVCHIN D A,SPEERS A E,et al. Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance[J]. J Am Chem Soc,2011,133(41):16605-16616.
LONE A M,BACHOVCHON D A,WESTWOOD D B,et al. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors[J].J Am Chem Soc,2011,133(30):11665-11674.
LIU Z Y,ZHOU Y,LIU J,et al. Reductive methylation labeling,from quantitative to structural proteomics[J]. TrAC-Trend Anal Chem,2019,118:771-778.
ZHOU Y,LIU Z Y,ZHANG J B,et al. Prediction of ligand modulation patterns on membrane receptors via lysine reactivity profiling[J].Chem Commun(Camb),2019,55(30):4311-4314.
CHEN J,WANG A H,LIU B,et al. Quantitative Lysine Reactivity Profiling Reveals Conformational Inhibition Dynamics and Potency of Aurora A Kinase Inhibitors[J]. Anal Chem,2019,91(20):13222-13229.
CHEN T R,WEI L H,GUAN X Q,et al. Biflavones from Ginkgo biloba as inhibitors of human thrombin[J].Bioorg Chem,2019,92:103199.
SUTANDY F X,QIAN J,CHEN C S,et al. Overview of protein microarrays[J].Curr Protoc Protein Sci,2013,27(1):Unit 27.1. doi:10.1002/0471140864.ps2701s72http://doi.org/10.1002/0471140864.ps2701s72.
GUPTA S,MANUBHAI K P,KULKARNI V,et al. An overview of innovations and industrial solutions in Protein Microarray Technology[J].Proteomics,2016,16(8):1297-1308.
FUENTES M. Protein microarrays overview[J]. Recent Pat Biotechnol,2013,7(2):83.doi:10.2174/1872208311307020001http://doi.org/10.2174/1872208311307020001.
YAO C X,WANG T,ZHANG B Q,et al.Screening of the binding of small molecules to proteins by desorption electrospray ionization mass spectrometry combined with protein microarray[J].J Am Soc Mass Spectrom,2015,26(11):1950-1958.
BAE N,VIVIANO M,SU X N,et al. Developing Spindlin1 small-molecule inhibitors by using proteinmicroarrays[J]. Nat Chem Biol,2017,13(7):750-756.
EPPINGER J,FUNERIU D P,MIYAKE M,et al. Enzyme microarrays:On-chip determination of inhibition constants based on affinity-label detection of enzymatic activity[J].Angew Chem Int Ed Engl,2004,43(29):3806-3810.
FUNERIU D P,EPPINGER J,DENIZOT L,et al. Enzyme family-specific and activity-based screening of chemical libraries using enzyme microarrays[J].Nat Biotechnol,2005,23(5):622-627.
WU J J,GUAN X Q,DAI Z R,et al. Molecular probes for human cytochrome P450 enzymes:Recent progress and future perspectives[EB/OL].Coord Chem Rev,2021,427:213600.https://doi.org/10.1016/j.ccr.2020.213600https://doi.org/10.1016/j.ccr.2020.213600.
HUO P C,GUAN X Q,LIU P,et al. Design,synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors[J]. Eur J Med Chem,2020,209:112856.doi:10.1016/j.ejmech.2020.112856http://doi.org/10.1016/j.ejmech.2020.112856.
0
浏览量
713
下载量
0
CSCD
5
CNKI被引量
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621